— Know what they know.
Not Investment Advice

371470.KS

TIGER China Biotech Solactive
1W: -1.1% 1M: +3.1% 3M: +4.9% YTD: -3.4% 1Y: +1.3% 3Y: +37.8% 5Y: -33.4%
₩8,680.00 ($6.47)
-125.00 (-1.42%)
 
Weekly Expected Move ±4.6%
₩7880 ₩8280 ₩8680 ₩9080 ₩9480
ETF KSC · AUM ₩48.0B

Portfolio Health Summary

IS Overall Score
75.5
★★★★★
Altman Z-Score
15.91
Safe
Weight Coverage
59%
of portfolio analyzed
Holdings Matched
14
with fundamental data

InsiderStreet Scorecard

★★★★★ 75.5
Profitability
67.6
Balance Sheet
86.3
Earnings Quality
56.7
Growth
68.8
Value
40.7
Momentum
82.9
Safety
99.2

Top Holdings: Score Breakdown

Risk & Quality Signals

Altman Z-Score
15.91
Safe Zone (>2.99)
Piotroski F-Score
6.5 / 9
Moderate
Beneish M-Score
-1.85
Unlikely Manipulator
Credit Score
—
Earnings Quality
56.7 / 100

Portfolio Valuation

P/E
26.92x
P/B
5.54x
P/S
5.76x
EV/EBITDA
14.87x
EV/Revenue
4.57x
P/FCF
23.13x
P/OCF
16.43x
PEG
0.53x
Earnings Yield
3.71%
FCF Yield
4.32%
OCF Yield
6.09%
Median P/E
12.93x

Growth & Shareholder Returns

Year-over-Year Growth

Revenue +44.3%
Net Income +100.5%
EPS +98.4%
FCF +120.9%
EBITDA +105.2%
Op. Income —

Compound Growth Rates

Rev CAGR 3Y +65.7%
Rev CAGR 5Y +45.3%
EPS CAGR 3Y +51.0%
EPS CAGR 5Y +66.8%
FCF CAGR 3Y +40.6%
FCF CAGR 5Y +41.0%
EBITDA CAGR 3Y +73.5%
EBITDA CAGR 5Y +50.3%
Payout Ratio
6.04%
Buyback Yield
0.02%
Dividend Yield
0.42%
Total Shareholder Return
0.02%

Earnings Stability

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1393 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$8680.00
Median 1Y
$8073.34
5th Pctile
$4932.93
95th Pctile
$13295.51
Ann. Volatility
30.8%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics
Valuation (12)
MetricValue
Portfolio P/E 26.92
Portfolio P/B 5.54
Portfolio P/S 5.76
EV/EBITDA 14.87
EV/Revenue 4.57
P/FCF 23.13
P/OCF 16.43
PEG 0.53
Earnings Yield 3.71%
FCF Yield 4.32%
OCF Yield 6.09%
Median P/E 12.93
Profitability & Returns (9)
MetricValue
Gross Margin 69.08%
Operating Margin 25.79%
Net Margin 20.38%
FCF Margin 24.25%
ROE 22.16%
ROA 14.16%
ROIC 37.69%
ROCE —
Asset Turnover —
Leverage & Solvency (6)
MetricValue
Debt/Equity 0.15
Debt/Assets 0.10
Net Debt/EBITDA -1.54
Interest Coverage 53.14
Current Ratio 2.84
Quick Ratio 2.66
Efficiency (4)
MetricValue
Asset Turnover —
Inventory Turnover —
Receivables Turnover —
Payables Turnover —
Growth — YoY (6)
MetricValue
Revenue Growth 44.31%
Net Income Growth 100.53%
EPS Growth 98.44%
FCF Growth 120.91%
EBITDA Growth 105.22%
Op. Income Growth —
Growth — CAGR (16)
MetricValue
Revenue CAGR 3Y 65.72%
Revenue CAGR 5Y 45.34%
Revenue CAGR 10Y —
EPS CAGR 3Y 51.04%
EPS CAGR 5Y 66.76%
EPS CAGR 10Y —
FCF CAGR 3Y 40.60%
FCF CAGR 5Y 41.02%
FCF CAGR 10Y —
EBITDA CAGR 3Y 73.48%
EBITDA CAGR 5Y 50.33%
EBITDA CAGR 10Y —
Net Income CAGR 3Y 51.56%
Net Income CAGR 5Y 70.31%
Op. Income CAGR 3Y —
Op. Income CAGR 5Y —
Quality Scores (13)
MetricValue
IS Overall 75.5
IS Profitability 67.6
IS Balance Sheet 86.3
IS Earnings Quality 56.7
IS Growth 68.8
IS Value 40.7
IS Momentum 82.9
IS Safety 99.2
IS Quality 76.2
Altman Z-Score 15.91
Piotroski F-Score 6.47
Beneish M-Score -1.85
Credit Score —
Dividends & Payout (4)
MetricValue
Dividend Yield 0.42%
Payout Ratio 6.04%
Buyback Yield 0.02%
Total Shareholder Return 0.02%
Growth Stability (4)
MetricValue
Revenue Stability 0.896
Earnings Stability 0.633
Earnings Persistence 0.435
Margin Stability 0.902
Medians (3)
MetricValue
Median P/E 12.93
Median P/B 4.52
Median Dividend Yield —
Coverage Meta (3)
MetricValue
Weight Coverage % 59.45%
Holdings Matched 14
Total Holdings —

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms